MedTrace Logo

Home Treatment of Patients With Pulmonary Embolism Based on Pro-Brain Natriuretic Peptide (BNP) Levels

NCT00455819 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2009-03-31

No results posted yet for this study

Summary

The aim of this study is to investigate the safety of treatment of pulmonary embolism in an outpatient setting based on normal pro-BNP levels. The mortality rate and the incidence of hemodynamic instability as well as major bleeding and recurrent venous thromboembolism (VTE) in the outpatient group will be studied.

Conditions

Interventions

PROCEDURE

home treatment

Sponsors & Collaborators

  • Diakonessenhuis, Utrecht

    collaborator OTHER

  • Groene Hart Ziekenhuis

    collaborator OTHER

  • Reinier de Graaf Groep

    collaborator OTHER

  • St. Antonius Hospital

    lead OTHER

Principal Investigators

  • Douwe H Biesma, D.H. · St. Antonius Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-12-31
Primary Completion
2009-03-31
Completion
2009-03-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00455819 on ClinicalTrials.gov